Drugs of Today focuses on the clinical development, efficacy, and safety of novel therapeutic agents across a range of diseases. Recent articles highlight the application of monoclonal antibodies, tyrosine kinase inhibitors, gene therapies, and other targeted treatments for conditions including various cancers, autoimmune disorders, and chronic diseases. The journal also covers advancements in drug administration and treatment strategies for conditions like HIV and osteoporosis.
Chronic Lymphocytic Leukemia ResearchLung Cancer Treatments and MutationsMonoclonal and Polyclonal Antibodies ResearchAsthma and respiratory diseasesDiabetes Treatment and ManagementHIV/AIDS drug development and treatmentLipoproteins and Cardiovascular HealthHormonal and reproductive studiesPharmaceutical Economics and PolicyHER2/EGFR in Cancer Research